Case studies

In the Field

AI/ML Innovations is advancing a broad portfolio of clinical, performance, and population-health initiatives designed to redefine how cardiac data is captured, cleaned, interpreted, and applied. Across world-class institutions — from pediatric research hospitals to cardiology centres, physiotherapy groups, and emerging international health systems — these pilots showcase the real-world validation of our MaxYield™ signal-processing engine, CardioYield™ Holter-reporting platform, and Insight360™ visualization suite.

MaxYield™

CardioYield™

Insight360™

CASE STUDY 01 · JAMAICA

Expanding access to cardiac diagnostics with AI-enhanced Holter reporting.

Affordable, high-accuracy ECG diagnostics in the Caribbean. AIML and Neural Cloud Solutions are working with leading clinical and regulatory partners in Jamaica to pilot CardioYield™ — a low-cost, AI-powered Holter-reporting platform paired with a single-lead ECG chest strap — addressing Jamaica's high burden of cardiovascular disease with accessible diagnostics suited to local care settings and tropical environments.

Through an active clinical pilot and a formal national regulatory submission, the program is designed to establish a scalable model for country-wide deployment — with the long-term goal of extending AI-enabled cardiac screening across Jamaica and, ultimately, throughout the Caribbean.

See updates

Active pilot · National regulatory submission

CASE STUDY 02 · SICKKIDS HOSPITAL

High-fidelity ECG processing for one of the world's top pediatric hospitals.

AI-driven ECG innovation in pediatric cardiac research. AI/ML Innovations has entered a pilot with The Hospital for Sick Children (SickKids) — one of the world's leading pediatric research institutions — to evaluate MaxYield™ in pediatric cardiac care, supporting an emerging research program focused on early detection of cardiac deterioration in children.

Led by Dr. Cedric Manlhiot, an internationally recognized expert in pediatric cardiovascular data science, the project assesses MaxYield's ability to enhance ECG signal quality, provide structured beat-level analysis, and contribute to multimodal predictive models that improve early-warning systems for vulnerable pediatric patients.

See updates

Dr. Cedric Manlhiot · Pediatric cardiovascular data science

CASE STUDY 03 · TORONTO HEART CENTRE

Validating AI-powered Holter reporting in a high-volume clinic.

Comparing AI-enhanced ECG reporting against standard clinical software. AI/ML Innovations has launched a pilot study with the Toronto Heart Centre to evaluate CardioYield™ — built on MaxYield™ — directly against the clinic's current industry-standard Holter software, measuring technician efficiency, signal clarity, report turnaround time, and overall diagnostic workflow performance.

Partnering with a leading cardiology group of more than 20 specialists from St. Michael's Hospital, the pilot aims to quantify real-world gains in throughput and reporting accuracy — validating how CardioYield™ can support high-volume clinical environments and modernize Holter analysis across Canadian cardiac practices.

See updates

20+ specialists · St. Michael's Hospital

CASE STUDY 04 · CORNERSTONE PHYSIOTHERAPY

AI-cleaned ECG signals to support Hyrox athlete performance analysis.

Bringing AI-enhanced cardiac insights to high-performance training. AIML has entered a pilot with Cornerstone Physiotherapy to evaluate MaxYield™ and Insight360™ within its elite athlete performance program — focusing on competitive Hyrox athletes and how AI-enhanced 1-lead ECG data supports high-intensity training insights, fatigue monitoring, and cardiac efficiency analysis.

Insight360™, Neural Cloud's customizable reporting layer, generates structured performance summaries that physiotherapists and coaches can interpret in real time. The pilot supports Neural Cloud's broader expansion into sports science and human performance markets.

See updates

Hyrox athletes · Sports science & human performance

Coming soon

More pilots and partnerships in development.

Additional case studies will be added as pilots progress and results are available. Baker Heart and Diabetes Institute (research services agreement signed March 2026) is a candidate for inclusion once work is underway.